Login/Sign Up
₹2785
(Inclusive of all Taxes)
Get ₹417.75 cashback (15%) with
Provide Delivery Location
Online payment accepted
Whats That
About Romy 125 mcg Injection 0.25 ml
Romy 125 mcg Injection 0.25 ml belongs to the class of 'platelet-stimulating agents' primarily used to treat chronic immune thrombocytopenia in adults who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Immune thrombocytopenia, often called idiopathic thrombocytopenic purpura (ITP), is an immune disorder characterised by low platelet counts.
Romy 125 mcg Injection 0.25 ml contains 'Romiplostim,' which is a thrombopoietin receptor agonist that functions similarly to thrombopoietin. Romy 125 mcg Injection 0.25 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy 125 mcg Injection 0.25 ml helps treat immune thrombocytopenia effectively.
Romy 125 mcg Injection 0.25 ml will be administered by the healthcare professional. In some cases, Romy 125 mcg Injection 0.25 ml may cause common side effects like headache, joint pain, dizziness, trouble sleeping, muscle tenderness or weakness, pain in the arms and legs and indigestion. These side effects may vary individually. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Notify your doctor if you have allergic reactions to Romy 125 mcg Injection 0.25 ml or other medications. You must inform your doctor if you have leukaemia (blood or bone marrow cancer), bleeding or clotting disorders, or heart, kidney, or liver problems. Romy 125 mcg Injection 0.25 ml is not recommended during pregnancy unless indicated by the doctor. Romy 125 mcg Injection 0.25 ml may make you dizzy; hence drive or operate machinery only when you are alert. Romy 125 mcg Injection 0.25 ml is not recommended for use during breastfeeding.
Uses of Romy 125 mcg Injection 0.25 ml
Directions for Use
Medicinal Benefits
Romy 125 mcg Injection 0.25 ml contains 'Romiplostim' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune thrombocytopenia. Romy 125 mcg Injection 0.25 ml promotes platelet formation by activating the thrombopoietin receptor. Thereby, Romy 125 mcg Injection 0.25 ml helps treat immune thrombocytopenia effectively.
Storage
Drug Warnings
Before beginning Romy 125 mcg Injection 0.25 ml, notify your doctor if you have had any allergic reactions to Romy 125 mcg Injection 0.25 ml or any other medications. You must notify your doctor if you have blood or bone marrow cancer (leukaemia), bleeding or clotting disorders, heart, kidney, or liver problems. Romy 125 mcg Injection 0.25 ml is not recommended during pregnancy unless indicated by the doctor. Romy 125 mcg Injection 0.25 ml may make you dizzy hence do not attempt to drive or operate machinery until you are physically stable and mentally alert. Romy 125 mcg Injection 0.25 ml should never be used to normalize platelet counts; Romy 125 mcg Injection 0.25 ml should only be used in ITP patients whose thrombocytopenia and clinical condition increase the risk of bleeding. Romy 125 mcg Injection 0.25 ml is not recommended for use during breastfeeding.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Drug-Diseases Interactions
Login/Sign Up
Romy 125 mcg Injection 0.25 ml contains Romiplostim, which promotes platelet formation by activating the thrombopoietin receptor. Thus Romy 125 mcg Injection 0.25 ml lowers the risk of bleeding episodes in diseases like immune thrombocytopenia and other associated conditions.
Immune thrombocytopenia is an autoimmune disorder in which the immune system misidentifies platelets as foreign bodies and destroys them. It can occur due to a virus, vaccination, or certain drugs. But the origin is unknown in the majority of cases.
Romy 125 mcg Injection 0.25 ml is only advised for patients who have not responded adequately to other treatments such as corticosteroids, immunoglobulins, or splenectomy.
Idiopathic thrombocytopenic purpura is typically diagnosed with blood tests such as complete blood count and antiplatelet-antibody test.
Romy 125 mcg Injection 0.25 ml is not approved to treat thrombocytopenia caused by Myelodysplastic syndrome (MDS) or any other cause of thrombocytopenia apart from chronic ITP.
Drug-Drug Interactions Checker List
Disease/Condition Glossary
Immune thrombocytopenia: It is an immune disorder characterised by low platelet counts and abnormal blood clotting. It happens when the immune system destroys its own platelets by mistake. Immune thrombocytopenia symptoms include easy bruising, bleeding from the gums and nose, blood in the urine and stools, heavy menstruation, and pinpoint-sized reddish-purple patches on the lower thighs.
Have a query?